Diabetes mellitus might be a protective factor of glioma
Aims: Several studies suggested that diabetes mellitus (DM) was associated with the risk of glioma. However, other studies did not confirm the result. Therefore, I conducted this meta-analysis. Materials and Methods: I retrieved the PubMed, Embase, and Web of Science database, by adopting keywords &...
Gespeichert in:
Veröffentlicht in: | Journal of cancer research and therapeutics 2018-09, Vol.14 (10), p.644-647 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 647 |
---|---|
container_issue | 10 |
container_start_page | 644 |
container_title | Journal of cancer research and therapeutics |
container_volume | 14 |
creator | Ni, Ting-Ting |
description | Aims: Several studies suggested that diabetes mellitus (DM) was associated with the risk of glioma. However, other studies did not confirm the result. Therefore, I conducted this meta-analysis.
Materials and Methods: I retrieved the PubMed, Embase, and Web of Science database, by adopting keywords "glioma," and "diabetes," "DM." The strength of the associations between DM and the risk of glioma was measured by odds ratios (ORs) with 95% confidence intervals (95% CIs).
Results: Ten relevant studies were identified in the final analysis. A statistically significant association between DM and glioma risk was fond (OR = 0.84; 95% CI, 0.73-0.97; P = 0.02). In the subgroup analysis of age group, young population with DM showed decreased glioma risk (OR = 0.83; 95% CI, 0.70-0.98; P = 0.02), whereas old population with DM did not show a significant association (OR = 0.87; 95% CI, 0.65-1.16; P = 0.34). In the subgroup analysis of gender, male patients with DM showed decreased glioma risk (OR = 0.82; 95% CI, 0.68-0.99; P = 0.04), whereas female population with DM did not show a significant association (OR = 0.93; 95% CI, 0.70-1.24; P = 0.63).
Conclusions: This meta-analysis suggested that DM may be associated with the reduced glioma risk. |
doi_str_mv | 10.4103/0973-1482.183184 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2112193599</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A555639438</galeid><sourcerecordid>A555639438</sourcerecordid><originalsourceid>FETCH-LOGICAL-c533s-d10de09334d052099a7e7e93b00d9b04ecc5c27e2c01c3b550d588c7b57fd0eb3</originalsourceid><addsrcrecordid>eNptks1vFCEYxonR2LV692Qm8eJl1pevAsda60fSxIueCcO8s9LODBUYN_73Zd12Y82GAwR-z5MHHgh5TWEtKPD3YBRvqdBsTTWnWjwhK2qMbgXl-ilZHY5PyIucrwGkYkw_JyccmDBa0xXRH4PrsGBuJhzHUJa6CJufpemwcc1tigV9Cb-xGZwvMTVxaDZjiJN7SZ4Nbsz46n4-JT8-XX6_-NJeffv89eL8qvWS89z2FHoEw7noQTIwxilUaHgH0JsOBHovPVPIPFDPOymhl1p71Uk19IAdPyXv9r41y68Fc7FTyL5mdTPGJVtGKaOGS2Mq-vY_9Douaa7p_lKgtKoPc6A2bkQb5iGW5PzO1J5LKc-4EVxXqj1CbXDG5MY44xDq9iN-fYSvo8cp-KMC2At8ijknHOxtCpNLfywFuyvX7tqzu_bsvtwqeXN_v6WbsD8IHtqswIc9sI1jwZRvxmWLyVb2Zo7bR8btP8b2TAj78A_4HVpssAI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2112078741</pqid></control><display><type>article</type><title>Diabetes mellitus might be a protective factor of glioma</title><source>MEDLINE</source><source>Medknow Open Access Medical Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Ni, Ting-Ting</creator><creatorcontrib>Ni, Ting-Ting</creatorcontrib><description>Aims: Several studies suggested that diabetes mellitus (DM) was associated with the risk of glioma. However, other studies did not confirm the result. Therefore, I conducted this meta-analysis.
Materials and Methods: I retrieved the PubMed, Embase, and Web of Science database, by adopting keywords "glioma," and "diabetes," "DM." The strength of the associations between DM and the risk of glioma was measured by odds ratios (ORs) with 95% confidence intervals (95% CIs).
Results: Ten relevant studies were identified in the final analysis. A statistically significant association between DM and glioma risk was fond (OR = 0.84; 95% CI, 0.73-0.97; P = 0.02). In the subgroup analysis of age group, young population with DM showed decreased glioma risk (OR = 0.83; 95% CI, 0.70-0.98; P = 0.02), whereas old population with DM did not show a significant association (OR = 0.87; 95% CI, 0.65-1.16; P = 0.34). In the subgroup analysis of gender, male patients with DM showed decreased glioma risk (OR = 0.82; 95% CI, 0.68-0.99; P = 0.04), whereas female population with DM did not show a significant association (OR = 0.93; 95% CI, 0.70-1.24; P = 0.63).
Conclusions: This meta-analysis suggested that DM may be associated with the reduced glioma risk.</description><identifier>ISSN: 0973-1482</identifier><identifier>EISSN: 1998-4138</identifier><identifier>DOI: 10.4103/0973-1482.183184</identifier><identifier>PMID: 30249881</identifier><language>eng</language><publisher>India: Wolters Kluwer India Pvt. Ltd</publisher><subject>Adult ; Age ; Age Factors ; Aged ; Autophagy ; Cancer ; Cell cycle ; Complications and side effects ; Diabetes ; Diabetes Complications - epidemiology ; Diabetes Complications - pathology ; Diabetes mellitus ; Diabetes Mellitus - epidemiology ; Diabetes Mellitus - pathology ; Female ; Gender ; Glioma ; Glioma - complications ; Glioma - epidemiology ; Glioma - pathology ; Gliomas ; Humans ; Kinases ; Male ; Meta-analysis ; Middle Aged ; Mortality ; Protective Factors ; Quality ; Risk Factors ; Sex Characteristics ; Sex Factors ; Studies</subject><ispartof>Journal of cancer research and therapeutics, 2018-09, Vol.14 (10), p.644-647</ispartof><rights>COPYRIGHT 2018 Medknow Publications and Media Pvt. Ltd.</rights><rights>2018. This work is published under https://creativecommons.org/licenses/by-nc-sa/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c533s-d10de09334d052099a7e7e93b00d9b04ecc5c27e2c01c3b550d588c7b57fd0eb3</citedby><cites>FETCH-LOGICAL-c533s-d10de09334d052099a7e7e93b00d9b04ecc5c27e2c01c3b550d588c7b57fd0eb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27435,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30249881$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ni, Ting-Ting</creatorcontrib><title>Diabetes mellitus might be a protective factor of glioma</title><title>Journal of cancer research and therapeutics</title><addtitle>J Cancer Res Ther</addtitle><description>Aims: Several studies suggested that diabetes mellitus (DM) was associated with the risk of glioma. However, other studies did not confirm the result. Therefore, I conducted this meta-analysis.
Materials and Methods: I retrieved the PubMed, Embase, and Web of Science database, by adopting keywords "glioma," and "diabetes," "DM." The strength of the associations between DM and the risk of glioma was measured by odds ratios (ORs) with 95% confidence intervals (95% CIs).
Results: Ten relevant studies were identified in the final analysis. A statistically significant association between DM and glioma risk was fond (OR = 0.84; 95% CI, 0.73-0.97; P = 0.02). In the subgroup analysis of age group, young population with DM showed decreased glioma risk (OR = 0.83; 95% CI, 0.70-0.98; P = 0.02), whereas old population with DM did not show a significant association (OR = 0.87; 95% CI, 0.65-1.16; P = 0.34). In the subgroup analysis of gender, male patients with DM showed decreased glioma risk (OR = 0.82; 95% CI, 0.68-0.99; P = 0.04), whereas female population with DM did not show a significant association (OR = 0.93; 95% CI, 0.70-1.24; P = 0.63).
Conclusions: This meta-analysis suggested that DM may be associated with the reduced glioma risk.</description><subject>Adult</subject><subject>Age</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Autophagy</subject><subject>Cancer</subject><subject>Cell cycle</subject><subject>Complications and side effects</subject><subject>Diabetes</subject><subject>Diabetes Complications - epidemiology</subject><subject>Diabetes Complications - pathology</subject><subject>Diabetes mellitus</subject><subject>Diabetes Mellitus - epidemiology</subject><subject>Diabetes Mellitus - pathology</subject><subject>Female</subject><subject>Gender</subject><subject>Glioma</subject><subject>Glioma - complications</subject><subject>Glioma - epidemiology</subject><subject>Glioma - pathology</subject><subject>Gliomas</subject><subject>Humans</subject><subject>Kinases</subject><subject>Male</subject><subject>Meta-analysis</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Protective Factors</subject><subject>Quality</subject><subject>Risk Factors</subject><subject>Sex Characteristics</subject><subject>Sex Factors</subject><subject>Studies</subject><issn>0973-1482</issn><issn>1998-4138</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptks1vFCEYxonR2LV692Qm8eJl1pevAsda60fSxIueCcO8s9LODBUYN_73Zd12Y82GAwR-z5MHHgh5TWEtKPD3YBRvqdBsTTWnWjwhK2qMbgXl-ilZHY5PyIucrwGkYkw_JyccmDBa0xXRH4PrsGBuJhzHUJa6CJufpemwcc1tigV9Cb-xGZwvMTVxaDZjiJN7SZ4Nbsz46n4-JT8-XX6_-NJeffv89eL8qvWS89z2FHoEw7noQTIwxilUaHgH0JsOBHovPVPIPFDPOymhl1p71Uk19IAdPyXv9r41y68Fc7FTyL5mdTPGJVtGKaOGS2Mq-vY_9Douaa7p_lKgtKoPc6A2bkQb5iGW5PzO1J5LKc-4EVxXqj1CbXDG5MY44xDq9iN-fYSvo8cp-KMC2At8ijknHOxtCpNLfywFuyvX7tqzu_bsvtwqeXN_v6WbsD8IHtqswIc9sI1jwZRvxmWLyVb2Zo7bR8btP8b2TAj78A_4HVpssAI</recordid><startdate>20180901</startdate><enddate>20180901</enddate><creator>Ni, Ting-Ting</creator><general>Wolters Kluwer India Pvt. Ltd</general><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications & Media Pvt. Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20180901</creationdate><title>Diabetes mellitus might be a protective factor of glioma</title><author>Ni, Ting-Ting</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c533s-d10de09334d052099a7e7e93b00d9b04ecc5c27e2c01c3b550d588c7b57fd0eb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adult</topic><topic>Age</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Autophagy</topic><topic>Cancer</topic><topic>Cell cycle</topic><topic>Complications and side effects</topic><topic>Diabetes</topic><topic>Diabetes Complications - epidemiology</topic><topic>Diabetes Complications - pathology</topic><topic>Diabetes mellitus</topic><topic>Diabetes Mellitus - epidemiology</topic><topic>Diabetes Mellitus - pathology</topic><topic>Female</topic><topic>Gender</topic><topic>Glioma</topic><topic>Glioma - complications</topic><topic>Glioma - epidemiology</topic><topic>Glioma - pathology</topic><topic>Gliomas</topic><topic>Humans</topic><topic>Kinases</topic><topic>Male</topic><topic>Meta-analysis</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Protective Factors</topic><topic>Quality</topic><topic>Risk Factors</topic><topic>Sex Characteristics</topic><topic>Sex Factors</topic><topic>Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ni, Ting-Ting</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cancer research and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ni, Ting-Ting</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diabetes mellitus might be a protective factor of glioma</atitle><jtitle>Journal of cancer research and therapeutics</jtitle><addtitle>J Cancer Res Ther</addtitle><date>2018-09-01</date><risdate>2018</risdate><volume>14</volume><issue>10</issue><spage>644</spage><epage>647</epage><pages>644-647</pages><issn>0973-1482</issn><eissn>1998-4138</eissn><abstract>Aims: Several studies suggested that diabetes mellitus (DM) was associated with the risk of glioma. However, other studies did not confirm the result. Therefore, I conducted this meta-analysis.
Materials and Methods: I retrieved the PubMed, Embase, and Web of Science database, by adopting keywords "glioma," and "diabetes," "DM." The strength of the associations between DM and the risk of glioma was measured by odds ratios (ORs) with 95% confidence intervals (95% CIs).
Results: Ten relevant studies were identified in the final analysis. A statistically significant association between DM and glioma risk was fond (OR = 0.84; 95% CI, 0.73-0.97; P = 0.02). In the subgroup analysis of age group, young population with DM showed decreased glioma risk (OR = 0.83; 95% CI, 0.70-0.98; P = 0.02), whereas old population with DM did not show a significant association (OR = 0.87; 95% CI, 0.65-1.16; P = 0.34). In the subgroup analysis of gender, male patients with DM showed decreased glioma risk (OR = 0.82; 95% CI, 0.68-0.99; P = 0.04), whereas female population with DM did not show a significant association (OR = 0.93; 95% CI, 0.70-1.24; P = 0.63).
Conclusions: This meta-analysis suggested that DM may be associated with the reduced glioma risk.</abstract><cop>India</cop><pub>Wolters Kluwer India Pvt. Ltd</pub><pmid>30249881</pmid><doi>10.4103/0973-1482.183184</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0973-1482 |
ispartof | Journal of cancer research and therapeutics, 2018-09, Vol.14 (10), p.644-647 |
issn | 0973-1482 1998-4138 |
language | eng |
recordid | cdi_proquest_miscellaneous_2112193599 |
source | MEDLINE; Medknow Open Access Medical Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Adult Age Age Factors Aged Autophagy Cancer Cell cycle Complications and side effects Diabetes Diabetes Complications - epidemiology Diabetes Complications - pathology Diabetes mellitus Diabetes Mellitus - epidemiology Diabetes Mellitus - pathology Female Gender Glioma Glioma - complications Glioma - epidemiology Glioma - pathology Gliomas Humans Kinases Male Meta-analysis Middle Aged Mortality Protective Factors Quality Risk Factors Sex Characteristics Sex Factors Studies |
title | Diabetes mellitus might be a protective factor of glioma |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T18%3A04%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diabetes%20mellitus%20might%20be%20a%20protective%20factor%20of%20glioma&rft.jtitle=Journal%20of%20cancer%20research%20and%20therapeutics&rft.au=Ni,%20Ting-Ting&rft.date=2018-09-01&rft.volume=14&rft.issue=10&rft.spage=644&rft.epage=647&rft.pages=644-647&rft.issn=0973-1482&rft.eissn=1998-4138&rft_id=info:doi/10.4103/0973-1482.183184&rft_dat=%3Cgale_proqu%3EA555639438%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2112078741&rft_id=info:pmid/30249881&rft_galeid=A555639438&rfr_iscdi=true |